Europe Cell Culture Media Market Analysis

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Europe Cell Culture Media Market Analysis

  • Healthcare
  • Published Report
  • Oct 2024
  • Europe
  • 350 Pages
  • No of Tables: 126
  • No of Figures: 33

Cell culture media market analysis involves evaluating the global and regional trends, key players, growth factors, challenges, and emerging opportunities in the market for cell culture media. Cell culture media are vital for the growth and maintenance of cells in laboratories and are essential in areas such as biopharmaceutical production, academic research, drug discovery, and regenerative medicine. Moreover,  rise in R&D expenditure and rise in productition of  vaccine driving the market growth.

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE EUROPE CELL CULTURE MEDIA MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 DBMR TRIPOD DATA VALIDATION MODEL

2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.6 MULTIVARIATE MODELLING

2.7 MARKET APPLICATION COVERAGE GRID

2.8 PRODUCT LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTERS FIVE FORCES ANALYSIS

5 EUROPE CELL CULTURE MEDIA MARKET: REGULATIONS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASING FOCUS ON PERSONALIZED MEDICINE

6.1.2 ADVANCES IN CELL THERAPY AND REGENERATIVE MEDICINE

6.1.3 INCREASE IN R&D SPENDING ON BIOPHARMACEUTICAL PROJECTS

6.1.4 GROWING DEMAND FOR VACCINE DEVELOPMENT

6.2 RESTRAINTS

6.2.1 RISKS ASSOCIATED WITH CONTAMINATION

6.2.2 HIGH COST OF PRODUCTION

6.3 OPPORTUNITIES

6.3.1 RISING COLLABORATION AND PARTNERSHIPS

6.3.2 INCREASED DEMAND FOR BIOPHARMACEUTICALS AND VACCINES

6.3.3 INNOVATIONS IN 3D CELL CULTURE

6.4 CHALLENGES

6.4.1 COMPLEXITY OF MEDIA FORMULATION

6.4.2 INTENSE MARKET COMPETITION

7 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE

7.1 OVERVIEW

7.2 CHEMICALLY DEFINED MEDIA

7.3 CLASSICAL MEDIA

7.4 SERUM-FREE MEDIA

7.4.1 CHO MEDIA

7.4.2 HEK 293 MEDIA

7.4.3 CAR T-CELL MEDIA

7.4.4 VERO CELL MEDIA

7.4.5 BHK MEDIA

7.4.6 INSECT CELL MEDIA

7.4.7 SERUM-FREE CELL MEDIA

7.4.8 OTHER SERUM-FREE MEDIA

7.5 SPECIALTY MEDIA

7.6 STEM CELL MEDIA

7.6.1 MESENCHYMAL STEM CELLS (MSCS)

7.6.2 NEURAL STEM CELLS (NSCS)

7.6.3 EMBRYONIC STEM CELLS (ESCS)

7.6.4 BONE MARROW

7.6.5 OTHERS

7.7 LYSOGENY BROTH (LB)

7.8 CUSTOM MEDIA FORMULATION

7.9 OTHERS

8 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION

8.1 OVERVIEW

8.2 BIOPHARMACEUTICAL PRODUCTION

8.2.1 MONOCLONAL ANTIBODIES

8.2.2 VACCINES PRODUCTION

8.2.3 OTHERS

8.3 DRUG SCREENING & DEVELOPMENT

8.4 DIAGNOSTICS

8.5 REGENERATIVE MEDICINE & TISSUE ENGINEERING

8.5.1 STEM CELL AND GENE THERAPY

8.5.2 OTHERS

8.6 OTHERS

9 EUROPE CELL CULTURE MEDIA MARKET, BY END USER

9.1 OVERVIEW

9.2 BIOPHARMACEUTICAL COMPANIES

9.3 BIOTECHNOLOGY ORGANIZATIONS

9.4 ACADEMIC AND RESEARCH LABORATORIES

9.5 HOSPITALS

9.6 DIAGNOSTIC CENTERS

9.7 CELL BANKS

9.8 FORENSIC LABORATORIES

9.9 OTHERS

10 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDERS

10.3 THIRD PARTY DISTRIBUTION

10.4 RETAILS SALES

11 EUROPE CELL CULTURE MEDIA MARKET, BY REGION

11.1 EUROPE

11.1.1 GERMANY

11.1.2 U.K.

11.1.3 FRANCE

11.1.4 NETHERLANDS

11.1.5 SPAIN

11.1.6 SWITZERLAND

11.1.7 BELGIUM

11.1.8 ITALY

11.1.9 RUSSIA

11.1.10 TURKEY

11.1.11 REST OF EUROPE

12 EUROPE MULTIPLE HEREDITARY EXOSTOSIS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: EUROPE

13 SWOT ANALYSIS

14 COMPANY PROFILES

14.1 THERMO FISHER SCIENTIFIC INC.

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 COMPANY SHARE ANALYSIS

14.1.4 PRODUCT PORTFOLIO

14.1.5 RECENT DEVELOPMENT

14.2 MERCK KGAA

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 COMPANY SHARE ANALYSIS

14.2.4 PRODUCT PORTFOLIO

14.2.5 RECENT DEVELOPMENTS

14.3 DANAHER CORPORATION (CYTIVA)

14.3.1 COMPANY SNAPSHOT

14.3.2 REVENUE ANALYSIS

14.3.3 COMPANY SHARE ANALYSIS

14.3.4 PRODUCT PORTFOLIO

14.3.5 RECENT DEVELOPMENTS

14.4 SARTORIUS AG

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 COMPANY SHARE ANALYSIS

14.4.4 PRODUCT PORTFOLIO

14.4.5 RECENT DEVELOPMENTS

14.5 LONZA

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 COMPANY SHARE ANALYSIS

14.5.4 PRODUCT PORTFOLIO

14.5.5 RECENT DEVELOPMENT

14.6 CORNING INCORPORATED

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 COMPANY SHARE ANALYSIS

14.6.4 PRODUCT PORTFOLIO

14.6.5 RECENT UPDATES

14.7 AJINOMOTO CO., INC

14.7.1 COMPANY SNAPSHOT

14.7.2 REVENUE ANALYSIS

14.7.3 PRODUCT PORTFOLIO

14.7.4 RECENT DEVELOPMENT

14.8 AKRON BIOTECH

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 BD

14.9.1 COMPANY SNAPSHOT

14.9.2 REVENUE ANALYSIS

14.9.3 PRODUCT PORTFOLIO

14.9.4 RECENT UPDATES

14.1 BIO-RAD LABORATORIES, INC.

14.10.1 COMPANY SNAPSHOT

14.10.2 REVENUE ANALYSIS

14.10.3 PRODUCT PORTFOLIO

14.10.4 RECENT DEVELOPMENT

14.11 CAISSON LABS INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 PRODUCT PORTFOLIO

14.11.3 RECENT UPDATES

14.12 CELL APPLICATION, INC.

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT UPDATES

14.13 ELEX BIOLOGICAL PRODUCTS (SHANGHAI) CO., LTD.

14.13.1 COMPANY SNAPSHOT

14.13.2 PRODUCT PORTFOLIO

14.13.3 RECENT DEVELOPMENT

14.14 FUJIFILM HOLDINGS CORPORATION

14.14.1 COMPANY SNAPSHOT

14.14.2 REVENUE ANALYSIS

14.14.3 PRODUCT PORTFOLIO

14.14.4 RECENT UPDATES

14.15 HIMEDIA LABORATORIES

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT UPDATES

14.16 KOH JIN-BIO CO., LTD.

14.16.1 COMPANY SNAPSHOT

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT UPDATES

14.17 PAN-BIOTECH

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT UPDATES

14.18 PROMOCELL GMBH

14.18.1 COMPANY SNAPSHOT

14.18.2 PRODUCT PORTFOLIO

14.18.3 RECENT UPDATES

14.19 SERA-SCANDIA A/S

14.19.1 COMPANY SNAPSHOT

14.19.2 PRODUCT PORTFOLIO

14.19.3 RECENT DEVELOPMENTS

14.2 STEMCELL TECHNOLOGIES

14.20.1 COMPANY SNAPSHOT

14.20.2 PRODUCT PORTFOLIO

14.20.3 RECENT DEVELOPMENT

14.21 TAKARA BIO INC.

14.21.1 COMPANY SNAPSHOT

14.21.2 REVENUE ANALYSIS

14.21.3 PRODUCT PORTFOLIO

14.21.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

TABLE 1 GMP REQUIREMENTS

TABLE 2 SCOPE OF THE CURRENT DOCUMENT

TABLE 3 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 4 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (VOLUME)

TABLE 5 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (ASP)

TABLE 6 EUROPE CHEMICALLY DEFINED MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 7 EUROPE CLASSICAL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 8 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 9 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 10 EUROPE SPECIALTY MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 11 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 12 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 13 EUROPE LYSOGENY BROTH (LB) IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 14 EUROPE CUSTOM MEDIA FORMULATION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 15 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 16 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 17 EUROPE BIOPHARMACEUTICAL PRODUCTION  IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 18 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 19 EUROPE DRUG SCREENING & DEVELOPMENT IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 20 EUROPE DIAGNOSTICS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 21 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 22 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 23 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 24 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 25 EUROPE BIOPHARMACEUTICAL COMPANIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 26 EUROPE BIOTECHNOLOGY ORGANIZATIONS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 27 EUROPE ACADEMIC AND RESEARCH LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 28 EUROPE HOSPITALS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 29 EUROPE DIAGNOSTIC CENTERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 30 EUROPE CELL BANKS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 31 EUROPE FORENSIC LABORATORIES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 32 EUROPE OTHERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 33 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 34 EUROPE DIRECT TENDERS IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 35 EUROPE THIRD PARTY DISTRIBUTION IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 36 EUROPE RETAIL SALES IN CELL CULTURE MEDIA MARKET, BY REGION, 2022-2031 (USD MILLION)

TABLE 37 EUROPE CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022-2031 (USD MILLION)

TABLE 38 EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 39 EUROPE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 40 EUROPE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 41 EUROPE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 42 EUROPE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 43 EUROPE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 44 EUROPE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 45 EUROPE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 46 GERMANY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 47 GERMANY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 48 GERMANY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 49 GERMANY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 50 GERMANY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 51 GERMANY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 52 GERMANY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 53 GERMANY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 54 U.K. CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 55 U.K. SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 56 U.K. STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 57 U.K. CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 58 U.K. BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 59 U.K. REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 60 U.K. CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 61 U.K. CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 62 FRANCE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 63 FRANCE SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 64 FRANCE STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 65 FRANCE CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 66 FRANCE BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 67 FRANCE REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 68 FRANCE CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 69 FRANCE CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 70 NETHERLANDS CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 71 NETHERLANDS SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 72 NETHERLANDS STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 73 NETHERLANDS CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 74 NETHERLANDS BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 75 NETHERLANDS REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 76 NETHERLANDS CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 77 NETHERLANDS CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 78 SPAIN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 79 SPAIN SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 80 SPAIN STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 81 SPAIN CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 82 SPAIN BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 83 SPAIN REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 84 SPAIN CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 85 SPAIN CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 86 SWITZERLAND CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 87 SWITZERLAND SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 88 SWITZERLAND STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 89 SWITZERLAND CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 90 SWITZERLAND BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 91 SWITZERLAND REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 92 SWITZERLAND CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 93 SWITZERLAND CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 94 BELGIUM CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 95 BELGIUM SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 96 BELGIUM STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 97 BELGIUM CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 98 BELGIUM BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 99 BELGIUM REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 100 BELGIUM CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 101 BELGIUM CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 102 ITALY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 103 ITALY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 104 ITALY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 105 ITALY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 106 ITALY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 107 ITALY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 108 ITALY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 109 ITALY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 110 RUSSIA CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 111 RUSSIA SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 112 RUSSIA STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 113 RUSSIA CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 114 RUSSIA BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 115 RUSSIA REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 116 RUSSIA CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 117 RUSSIA CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 118 TURKEY CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 119 TURKEY SERUM-FREE MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 120 TURKEY STEM CELL MEDIA IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 121 TURKEY CELL CULTURE MEDIA MARKET, BY APPLICATION, 2022-2031 (USD MILLION)

TABLE 122 TURKEY BIOPHARMACEUTICAL PRODUCTION IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 123 TURKEY REGENERATIVE MEDICINE & TISSUE ENGINEERING IN CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

TABLE 124 TURKEY CELL CULTURE MEDIA MARKET, BY END-USER, 2022-2031 (USD MILLION)

TABLE 125 TURKEY CELL CULTURE MEDIA MARKET, BY DISTRIBUTION CHANNEL, 2022-2031 (USD MILLION)

TABLE 126 REST OF EUROPE CELL CULTURE MEDIA MARKET, BY TYPE, 2022-2031 (USD MILLION)

List of Figure

FIGURE 1 EUROPE CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 2 EUROPE CELL CULTURE MEDIA MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE CELL CULTURE MEDIA MARKET: DROC ANALYSIS

FIGURE 4 EUROPE CELL CULTURE MEDIA MARKET: EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE CELL CULTURE MEDIA MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE CELL CULTURE MEDIA MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE CELL CULTURE MEDIA MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 EUROPE CELL CULTURE MEDIA MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE CELL CULTURE MEDIA MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE CELL CULTURE MEDIA MARKET: SEGMENTATION

FIGURE 11 EXECUTIVE SUMMARY

FIGURE 12 STRATEGIC DECISIONS

FIGURE 13 INCREASING FOCUS ON PERSONALIZED MEDICINE IS DRIVING THE GROWTH OF THE EUROPE CELL CULTURE MEDIA MARKET FROM 2024 TO 2031

FIGURE 14 THE CHEMICALLY DEFINED MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CELL CULTURE MEDIA MARKET IN 2024 AND 2031

FIGURE 15 DROC ANALYSIS

FIGURE 16 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, 2023

FIGURE 17 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, 2024-2031 (USD MILLION)

FIGURE 18 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, CAGR (2024-2031)

FIGURE 19 EUROPE CELL CULTURE MEDIA MARKET: BY TYPE, LIFELINE CURVE

FIGURE 20 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, 2023

FIGURE 21 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, 2024-2031 (USD MILLION)

FIGURE 22 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, CAGR (2024-2031)

FIGURE 23 EUROPE CELL CULTURE MEDIA MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 24 EUROPE CELL CULTURE MEDIA MARKET: BY END USER, 2023

FIGURE 25 EUROPE CELL CULTURE MEDIA MARKET: BY END USER, 2024-2031 (USD MILLION)

FIGURE 26 EUROPE CELL CULTURE MEDIA MARKET: BY END USER, CAGR (2024-2031)

FIGURE 27 EUROPE CELL CULTURE MEDIA MARKET: BY END USER, LIFELINE CURVE

FIGURE 28 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2023

FIGURE 29 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)

FIGURE 30 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)

FIGURE 31 EUROPE CELL CULTURE MEDIA MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 32 EUROPE CELL CULTURE MEDIA MARKET: SNAPSHOT

FIGURE 33 EUROPE CELL CULTURE MEDIA MARKET: COMPANY SHARE 2023 (%)

Frequently Asked Questions

The market is segmented based on Segmentation, By Type (Chemically Defined Media, Classical Media, Serum-Free Media, Specialty Media, Stem Cell Media, Lysogeny Broth (LB), Custom Media Formulation, and Others), Application (Biopharmaceutical Production, Drug Screening & Development, Diagnostics, Regenerative Medicine & Tissue Engineering, and Others), End-User (Biopharmaceutical Companies, Biotechnology Organizations, Academic and Research Laboratories, Hospitals, Diagnostic Centers, Cell Banks, Forensic Laboratories, and Others), Distribution Channel (Direct Tenders, Third Party Distribution, and Retails Sales) – Industry Trends and Forecast to 2031 .
The Europe Cell Culture Media Market size was valued at USD 1.72 USD Billion in 2023.
The Europe Cell Culture Media Market is projected to grow at a CAGR of 10.7% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada, and Mexico, Germany, U.K., France, Netherlands, Spain, Switzerland, Belgium, Italy, Russia, Turkey, and Rest of Europe.